Technical Analysis for ARMP - Armata Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
4.311 | 3.13% | 0.13 |
ARMP closed up 4.5 percent on Monday, August 19, 2019, on 1.78 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| See historical ARMP trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 3.13% | |
| Expansion Breakout | Bullish Swing Setup | 3.13% | |
| Pocket Pivot | Bullish Swing Setup | 3.13% | |
| Upper Bollinger Band Walk | Strength | 3.13% | |
| Above Upper BB | Strength | 3.13% | |
| Upper Bollinger Band Touch | Strength | 3.13% | |
| Upper Bollinger Band Touch | Strength | 7.78% | |
| 200 DMA Support | Bullish | 16.51% | |
| 20 DMA Support | Bullish | 16.51% | |
| 180 Bullish Setup | Bullish Swing Setup | 9.42% |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
- Sector: Healthcare
- Industry: Biotechnology
Armata is a clinical-stage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Armata's lead product candidate, AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. The Company is also developing and advancing a broad pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa, leveraging its proprietary phage-specific GMP manufacturing capabilities.
Medicine Biotechnology Medical Specialties Antibiotic Bacteria Multiple Drug Resistance Pseudomonas Gram Negative Bacteria Pathogenic Bacteria Pseudomonas Aeruginosa Drug Resistance Pseudomonadales
Medicine Biotechnology Medical Specialties Antibiotic Bacteria Multiple Drug Resistance Pseudomonas Gram Negative Bacteria Pathogenic Bacteria Pseudomonas Aeruginosa Drug Resistance Pseudomonadales
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more ARMP news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 19.18 |
| 52 Week Low | 2.1 |
| Average Volume | 24,833 |
| 200-Day Moving Average | 3.687 |
| 50-Day Moving Average | 3.4862 |
| 20-Day Moving Average | 3.6735 |
| 10-Day Moving Average | 3.848 |
| Average True Range | 0.2899 |
| ADX | 27.32 |
| +DI | 25.9405 |
| -DI | 10.1863 |
| Chandelier Exit (Long, 3 ATRs ) | 3.6005 |
| Chandelier Exit (Short, 3 ATRs ) | 4.2197 |
| Upper Bollinger Band | 4.142 |
| Lower Bollinger Band | 3.205 |
| Percent B (%b) | 1.04 |
| BandWidth | 25.50701 |
| MACD Line | 0.137 |
| MACD Signal Line | 0.094 |
| MACD Histogram | 0.043 |
| Fundamentals | Value |
|---|---|
| Market Cap | 36.57 Million |
| Num Shares | 8.75 Million |
| EPS | -10.05 |
| Price-to-Earnings (P/E) Ratio | -0.42 |
| Price-to-Sales | 91.54 |
| Price-to-Book | 0.98 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.83 | ||||
| Resistance 3 (R3) | 4.85 | 4.66 | 4.72 | ||
| Resistance 2 (R2) | 4.66 | 4.50 | 4.65 | 4.68 | |
| Resistance 1 (R1) | 4.42 | 4.39 | 4.54 | 4.40 | 4.65 |
| Pivot Point | 4.23 | 4.23 | 4.29 | 4.22 | 4.23 |
| Support 1 (S1) | 3.99 | 4.07 | 4.11 | 3.96 | 3.71 |
| Support 2 (S2) | 3.80 | 3.96 | 3.79 | 3.68 | |
| Support 3 (S3) | 3.56 | 3.80 | 3.64 | ||
| Support 4 (S4) | 3.53 |
